22/02/2026
The BioAsia 2026 Summit to which we participated was an extremely useful and insightful event, with "Queensland positioning itself as a key partner for Indian companies and institutions across clinical research, translational science and healthcare innovation [...]"
"Dr. Thu (Sue) Nguyen, founder and CEO of Clueo Clinicals, said Queensland provided one of the fastest approval pathways globally for early-phase clinical trials. She said approvals under Australia’s Clinical Trial Notification Scheme, overseen by the Therapeutic Goods Administration, could be secured within four to eight weeks, significantly faster than in many other jurisdictions."
We will post more proceedings from the summit in the coming days.
Read more:
Australia–India biotech collaboration is showing early gains under the trade pact, with Queensland emerging as a key partner for Indian firms in research and healthcare innovation.